Navigation Links
Varian Medical Systems Schedules Second Quarter FY2008 News Release and Conference Call
Date:3/25/2008

PALO ALTO, Calif., March 25 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) announced today that it will report results for second quarter of fiscal year 2008 following the close of regular trading on Wednesday, April 23, 2008. The news release will be followed by a teleconference available to all interested parties at 2:00 p.m. PT.

The Varian Medical Systems quarterly results can be accessed on April 23, 2008 via:

News Release: Contact Anne Rambo via phone at 650-424-5834 or via

e-mail at anne.rambo@varian.com to have a copy of the

news release faxed, or visit the Varian website at

http://www.varian.com/news.

Internet Simulcast: http://www.varian.com/investor

Teleconference: Telephone from within the U.S.:

-- Dial 1-800-599-9795 and enter access code 16952454

prior to the call at 2:00 p.m. PT/5:00 p.m. ET.

Telephone from outside the U.S.:

-- Dial 1-617-786-2905 and enter access code 16952454

prior to the call at 2:00 p.m. PT/5:00 p.m. ET.

*Note: If the number of lines allocated to the call is

exhausted, the webcast or replay should be utilized.

Replay: The teleconference will be rebroadcast until 8:00 p.m.

ET, Friday, April 25, 2008 and can be accessed by

phone or Web link as follows:

-- Telephone from within the U.S.: Dial 1-888-286-8010

and enter access code 36929389.

-- Telephone from outside the U.S.: Dial

1-617-801-6888 and enter access code 36929389.

-- Internet: Click on the "Quarterly Conference Call"

icon on the company's investor relations website at

http://www.varian.com/investor

Web conferences will be archived on the company website for a year. Additional information about Varian Medical Systems can be obtained on the company's website. Investors can subscribe to receive automatic "e-mail alerts" regarding Varian news and events via the company website at http://www.varian.com/investor.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,600 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.

FOR INFORMATION CONTACT:

Spencer Sias, (650) 424-5782

Vice President, Corporate Communications

and Investor Relations

spencer.sias@varian.com


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
2. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
3. Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery
4. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
5. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
6. New SPE Cation Exchange Technology From Varian Simplifies Extraction of Basic Compounds
7. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
8. Varian, Inc. Reports First Quarter 2008 Results
9. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):